Total Knee Periprosthetic Joint Infection in the Setting of Hematologic Malignancy: Considerations for Management

Total Knee Periprosthetic Joint Infection in the Setting of Hematologic Malignancy: Considerations for Management

Patients with malignancy are often profoundly immunocompromised due to chemotherapy, placing them at potential increased risk for periprosthetic joint infection (PJI). However, there is little information regarding PJI management in these patients. We describe 4 patients with a history of primary to...

Full description

Bibliographic Details
Main Authors: G. Barnes Bloom, BSCE, Simon C. Mears, MD, PhD, Paul K. Edwards, MD, C. Lowry Barnes, MD, Jeffrey B. Stambough, MD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Arthroplasty Today
Subjects:
Chemotherapy
Multiple myeloma
Total knee arthroplasty
Periprosthetic joint infection
DAIR
Two stage
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344120300662

Internet

http://www.sciencedirect.com/science/article/pii/S2352344120300662

Similar Items